Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetics of Low Dose Raltegravir

This study has been completed.
National Healthcare Group Pte Ltd, Singapore
Chulalongkorn University
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration Identifier:
First received: June 9, 2010
Last updated: October 29, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)